Formulation of sparingly soluble compounds by hot-melt extrusion

US10022337B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10022337-B2
Application numberUS-201415034242-A
CountryUS
Kind codeB2
Filing dateNov 14, 2014
Priority dateNov 15, 2013
Publication dateJul 17, 2018
Grant dateJul 17, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to formulation of sparingly-(water)-soluble compounds and its use as (or in a) food or feed product or dietary supplement.

First claim

Opening claim text (preview).

The invention claimed is: 1. A hot-melt extruded formulation comprising: (i) 0.5-50 wt-%, based on the total weight of the hot melt extruded formulation, of at least one compound having low permeability and low solubility selected from the group consisting of α-carotene, β-carotene, 8′-apo-β-carotenal, 8′-apo-β-carotenoic acid esters, canthaxanthin, astaxanthin, lycopene, lutein, zeaxanthin and crocetin, (ii) 50-99.5 wt-%, based on the total weight of the hot melt extruded formulation, of at least one polymeric carrier material selected from the group consisting of ethyl cellulose (EC), hydroxypropylmethyl cellulose (HPMC), alginate, chitosan, corn starch, potato starch, polyvinylpyrrolidon (PVP), polyvinylacetate (PVA), polylactic acid (PLA), poly(methacrylic acid-co-ethyl acrylate) and polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer, and (iii) up to about 40 wt-%, based on the total weight of the hot melt extruded formulation, of at least one plasticizer selected from the group consisting of ethylene glycol, 1,2-butylene glycol, 2,3-butylene glycol, styrene glycol, diethylene glycol, triethylene glycol, tetraethylene glycol, monopropylene glycol monoisopropyl ether, propylene glycol monoethyl ether, ethylene glycol monoethyl ether, diethylene glycol monoethyl ether, sorbitol lactate, ethyl lactate, butyl lactate, ethyl glycolate, dibutylsebacate, acetyltributylcitrate, triethyl citrate, acetyl triethyl citrate, tributyl citrate and allyl glycolate. 2. The hot-melt extruded formulation according to claim 1 , wherein the compound having low permeability and low solubility is in an amorphous form. 3. The hot-melt extruded formulation according to claim 1 , wherein the at least one plasticizer is present in an amount of 10-40 wt-%, based on the total weight of the hot-melt extruded formulation. 4. The hot-melt extruded formulation according to claim 1 , further comprising at least one antioxidant. 5. The hot-melt extruded formulation according to claim 4 , wherein the at least one antioxidant is selected from the group consisting of ascorbic acid, ascorbyl palmitate, butylated hydroxyanisole, butylated hydroxytoluene, hypophophorous acid, monothioglycerol, sodium ascorbate, sodium formaldehyde sulfoxylate, sodium metabisulfite, vitamin C, BHT, BHA, sodium bisulfite, vitamin E and derivatives thereof, and propyl gallate. 6. The hot-melt extruded formulation according to claim 4 , wherein the at least one antioxidant is present in an amount up to 5 wt-%, based on the total weight of the hot-melt extruded formulation. 7. The hot-melt extruded formulation according to claim 1 , wherein the formulation comprises: (i) 5-20 wt-%, based on the total weight of the hot melt extruded formulation, of the at least one compound having low permeability and low solubility, (ii) 80-95 wt-%, based on the total weight of the hot melt extruded formulation, of the at least one polymeric carrier material, and (iii) 10-40 wt-%, based on the total weight of the hot melt extruded formulation, of the at least one plasticizer. 8. The hot-melt extruded formulation according to claim 1 , wherein the formulation comprises: (i) 5-10 wt-%, based on the total weight of the hot melt extruded formulation, of the at least one compound having low permeability and low solubility, (ii) 90-95 wt-%, based on the total weight of the hot melt extruded formulation, of the at least one polymeric carrier material, and (iii) 10-40 wt-%, based on the total weight of the hot melt extruded formulation, of the at least one plasticizer. 9. A food product, feed product and/or dietary supplement comprising the hot-melt extruded formulation according to claim 1 . 10. A premix for a food product, feed product and/or dietary supplement comprising the hot-melt extruded formulation according to claim 1 . 11. A hot-melt extrusion process for the production of a hot melt extruded formulation, wherein the process comprising conducting hot-melt extrusion in the absence of a solvent of formulation components comprising: (i) 0.5-50 weight-% (wt-%), based on the total weight of the hot-melt extruded formulation, of at least one compound having low solubility selected from the group consisting of α-carotene, β-carotene, 8′-apo-β-carotenal, 8′-apo-β-carotenoic acid esters, canthaxanthin, astaxanthin, lycopene, lutein, zeaxanthin and crocetin, (ii) 50-99.5 wt-%, based on the total weight of the hot-melt extruded formulation, of at least one polymeric carrier material selected from the group consisting of ethyl cellulose (EC), hydroxypropylmethyl cellulose (HPMC), alginate, chitosan, corn starch, potato starch, polyvinylpyrrolidon (PVP), polyvinylacetate (PVA), polylactic acid (PLA), poly(methacrylic acid-co-ethyl acrylate) and polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer, and (iii) up to about 40 wt-%, based on the total weight of the hot melt extruded formulation, of at least one plasticizer selected from the group consisting of ethylene glycol, 1,2-butylene glycol, 2,3-butylene glycol, styrene glycol, diethylene glycol, triethylene glycol, tetraethylene glycol, monopropylene glycol monoisopropyl ether, propylene glycol monoethyl ether, ethylene glycol monoethyl ether, diethylene glycol monoethyl ether, sorbitol lactate, ethyl lactate, butyl lactate, ethyl glycolate, dibutylsebacate, acetyltributylcitrate, triethyl citrate, acetyl triethyl citrate, tributyl citrate and allyl glycolate. 12. The hot-melt extrusion process according to claim 11 , which comprises conducting hot-melt extrusion of 5-20 wt-% of component (i), 80-95 wt-% of component (ii) and 10-40 wt-% of component (iii). 13. The hot-melt extrusion process according to claim 11 , which comprises conducting hot-melt extrusion of 5-10 wt-% or component (i), 90-95 wt-% of component (ii) and 10-40 wt-% of component (iii).

Assignees

Inventors

Classifications

  • A61K31/015Primary

    carbocyclic · CPC title

  • with organic macromolecular compounds · CPC title

  • A23P30/20Primary

    Extruding · CPC title

  • containing oxygen as heteroatom (gums A23L29/25; sugar or sugar alcohols A23L29/30) · CPC title

  • A23K20/10Primary

    Organic substances · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10022337B2 cover?
The present invention relates to formulation of sparingly-(water)-soluble compounds and its use as (or in a) food or feed product or dietary supplement.
Who is the assignee on this patent?
Dsm Ip Assets Bv
What technology area does this patent fall under?
Primary CPC classification A61K31/015. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).